These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. p62(dok): a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Carpino N; Wisniewski D; Strife A; Marshak D; Kobayashi R; Stillman B; Clarkson B Cell; 1997 Jan; 88(2):197-204. PubMed ID: 9008160 [TBL] [Abstract][Full Text] [Related]
3. Negative regulation of p120GAP GTPase promoting activity by p210bcr/abl: implication for RAS-dependent Philadelphia chromosome positive cell growth. Skorski T; Kanakaraj P; Ku DH; Nieborowska-Skorska M; Canaani E; Zon G; Perussia B; Calabretta B J Exp Med; 1994 Jun; 179(6):1855-65. PubMed ID: 8195713 [TBL] [Abstract][Full Text] [Related]
4. Phosphotyrosine phosphatase activity prevents the detection of P210bcr/abl protein in mature cells in chronic myelogenous leukemia even by an immunoblotting technique. Shibata K; Nishimura J; Takahira H; Nawata H Leukemia; 1989 Sep; 3(9):615-9. PubMed ID: 2474729 [TBL] [Abstract][Full Text] [Related]
5. c-kit ligand stimulates tyrosine phosphorylation of a similar pattern of phosphotyrosyl proteins in primary primitive normal hematopoietic progenitors that are constitutively phosphorylated in comparable primitive progenitors in chronic phase chronic myelogenous leukemia. Wisniewski D; Strife A; Berman E; Clarkson B Leukemia; 1996 Feb; 10(2):229-37. PubMed ID: 8637231 [TBL] [Abstract][Full Text] [Related]
6. Role of Dok-1 and Dok-2 in leukemia suppression. Niki M; Di Cristofano A; Zhao M; Honda H; Hirai H; Van Aelst L; Cordon-Cardo C; Pandolfi PP J Exp Med; 2004 Dec; 200(12):1689-95. PubMed ID: 15611295 [TBL] [Abstract][Full Text] [Related]
8. Tyrosine phosphorylation of rasGAP and associated proteins in chronic myelogenous leukemia cell lines. Druker B; Okuda K; Matulonis U; Salgia R; Roberts T; Griffin JD Blood; 1992 May; 79(9):2215-20. PubMed ID: 1571536 [TBL] [Abstract][Full Text] [Related]
9. Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients. Maxwell SA; Kurzrock R; Parsons SJ; Talpaz M; Gallick GE; Kloetzer WS; Arlinghaus RB; Kouttab NM; Keating MJ; Gutterman JU Cancer Res; 1987 Mar; 47(6):1731-9. PubMed ID: 2434223 [TBL] [Abstract][Full Text] [Related]
10. Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein. Gotoh A; Miyazawa K; Ohyashiki K; Tauchi T; Boswell HS; Broxmeyer HE; Toyama K Exp Hematol; 1995 Oct; 23(11):1153-9. PubMed ID: 7556524 [TBL] [Abstract][Full Text] [Related]
11. Cell lines and peripheral blood leukocytes derived from individuals with chronic myelogenous leukemia display virtually identical proteins phosphorylated on tyrosine residues. Huhn RD; Posner MR; Rayter SI; Foulkes JG; Frackelton AR Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4408-12. PubMed ID: 2440021 [TBL] [Abstract][Full Text] [Related]
12. Protein tyrosine phosphatase 1B antagonizes signalling by oncoprotein tyrosine kinase p210 bcr-abl in vivo. LaMontagne KR; Flint AJ; Franza BR; Pandergast AM; Tonks NK Mol Cell Biol; 1998 May; 18(5):2965-75. PubMed ID: 9566916 [TBL] [Abstract][Full Text] [Related]
13. Interaction of the receptor tyrosine kinase p145c-kit with the p210bcr/abl kinase in myeloid cells. Hallek M; Danhauser-Riedl S; Herbst R; Warmuth M; Winkler A; Kolb HJ; Druker B; Griffin JD; Emmerich B; Ullrich A Br J Haematol; 1996 Jul; 94(1):5-16. PubMed ID: 8757502 [TBL] [Abstract][Full Text] [Related]
14. Molecular cloning and characterization of p56dok-2 defines a new family of RasGAP-binding proteins. Di Cristofano A; Carpino N; Dunant N; Friedland G; Kobayashi R; Strife A; Wisniewski D; Clarkson B; Pandolfi PP; Resh MD J Biol Chem; 1998 Feb; 273(9):4827-30. PubMed ID: 9478921 [TBL] [Abstract][Full Text] [Related]
15. Identification of CRKL as the constitutively phosphorylated 39-kD tyrosine phosphoprotein in chronic myelogenous leukemia cells. Nichols GL; Raines MA; Vera JC; Lacomis L; Tempst P; Golde DW Blood; 1994 Nov; 84(9):2912-8. PubMed ID: 7524758 [TBL] [Abstract][Full Text] [Related]
16. p210BCR/ABL induces formation of complexes containing focal adhesion proteins and the protooncogene product p120c-Cbl. Salgia R; Sattler M; Pisick E; Li JL; Griffin JD Exp Hematol; 1996 Feb; 24(2):310-3. PubMed ID: 8641358 [TBL] [Abstract][Full Text] [Related]
17. Tyrphostin induced growth inhibition: correlation with effect on p210bcr-abl autokinase activity in K562 chronic myelogenous leukemia. Kaur G; Gazit A; Levitzki A; Stowe E; Cooney DA; Sausville EA Anticancer Drugs; 1994 Apr; 5(2):213-22. PubMed ID: 8049505 [TBL] [Abstract][Full Text] [Related]
18. Tyrosine phosphorylation of p62dok by p210bcr-abl inhibits RasGAP activity. Kashige N; Carpino N; Kobayashi R Proc Natl Acad Sci U S A; 2000 Feb; 97(5):2093-8. PubMed ID: 10688886 [TBL] [Abstract][Full Text] [Related]
19. Activation of Src kinases p53/56lyn and p59hck by p210bcr/abl in myeloid cells. Danhauser-Riedl S; Warmuth M; Druker BJ; Emmerich B; Hallek M Cancer Res; 1996 Aug; 56(15):3589-96. PubMed ID: 8758931 [TBL] [Abstract][Full Text] [Related]
20. Phosphotyrosine antibodies identify the p210c-abl tyrosine kinase and proteins phosphorylated on tyrosine in human chronic myelogenous leukemia cells. Naldini L; Stacchini A; Cirillo DM; Aglietta M; Gavosto F; Comoglio PM Mol Cell Biol; 1986 May; 6(5):1803-11. PubMed ID: 2431286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]